Snapshot · S&P 1500 · generated 2026-09-02 21:22 UTC

SUPN — Supernus Pharmaceuticals, Inc.

UNDERVALUED (MOS +58.0%) · Quality 55/100

SUPN - Supernus Pharmaceuticals, Inc.
Data generated 2026-09-02 21:22 UTC (nightly scan, universe: S&P 1500).
Price: 44.03 USD
Intrinsic value: 104.88 USD
Margin of safety: +58.0%
Implied growth (reverse DCF): +4.9% (model assumes +16.0%)
Valuation: UNDERVALUED
Value Score: 35.7
Quality: 55/100
Moat score: 42 (erosion: watch)
UNDERVALUED (MOS +58.0%) - Quality 55/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/SUPN
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

44.03

Intrinsic value

104.88

Margin of safety

+58.0%

Implied growth (reverse DCF)

+4.9%

model assumes +16.0%

Value Score

35.7

Quality

Psychology

12.7

Discovery

7.2

price/volume attention only

Moat score

erosion: watch

Value Score: top 40% of S&P 1500 · Quality: bottom 34%

Open the interactive Deep Dive for SUPN →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/SUPN - see the API docs for the full read-only surface, including an MCP server for AI assistants.